Melissa Pink

4.0k total citations
12 papers, 252 citations indexed

About

Melissa Pink is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Melissa Pink has authored 12 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Hematology. Recurrent topics in Melissa Pink's work include Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Melissa Pink is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Melissa Pink collaborates with scholars based in United States. Melissa Pink's co-authors include Pamela Snodgrass, Dwaine F. Emerich, Raymond T. Bartus, Reginald L. Dean, Hua Xiong, Brant P. Hasler, Joanne Marsh, Floyd E. Bloom, Jennifer Proctor and Karen McGovern and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Melissa Pink

12 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Pink United States	8	106	89	69	52	32	12	252
Ron Batash Israel	8	181 1.7×	103 1.2×	93 1.3×	24 0.5×	16 0.5×	13	453
Andrey S. Bryukhovetskiy Russia	13	113 1.1×	107 1.2×	113 1.6×	16 0.3×	16 0.5×	30	350
Jérémy Guehennec France	5	114 1.1×	129 1.4×	91 1.3×	34 0.7×	20 0.6×	6	312
Jonas Blaes Germany	9	192 1.8×	143 1.6×	128 1.9×	13 0.3×	24 0.8×	14	434
Yannève Rolland Canada	10	194 1.8×	48 0.5×	83 1.2×	16 0.3×	18 0.6×	11	344
Samuel A. Sprowls United States	12	178 1.7×	89 1.0×	121 1.8×	48 0.9×	48 1.5×	23	464
Michal Hendrych Czechia	12	111 1.0×	86 1.0×	44 0.6×	11 0.2×	19 0.6×	32	336
Agatha Lyczek United States	8	164 1.5×	129 1.4×	24 0.3×	26 0.5×	31 1.0×	8	326
Laurine E. Wedekind Netherlands	12	265 2.5×	244 2.7×	127 1.8×	27 0.5×	10 0.3×	15	504
George A. Basler United States	10	115 1.1×	158 1.8×	109 1.6×	14 0.3×	33 1.0×	11	373

Countries citing papers authored by Melissa Pink

Since Specialization

Citations

This map shows the geographic impact of Melissa Pink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Pink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Pink more than expected).

Fields of papers citing papers by Melissa Pink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Pink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Pink. The network helps show where Melissa Pink may publish in the future.

Co-authorship network of co-authors of Melissa Pink

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Pink. A scholar is included among the top collaborators of Melissa Pink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Pink. Melissa Pink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kerrie, L., Kerry White, Jennifer Proctor, et al.. (2018). The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies. PLoS ONE. 13(8). e0200725–e0200725. 23 indexed citations

Henau, Olivier De, Taha Merghoub, David A. Winkler, et al.. (2016). Abstract 554: Checkpoint blockade therapy is improved by altering the immune suppressive microenvironment with IPI-549, a potent and selective inhibitor of PI3K-gamma, in preclinical models. Cancer Research. 76(14_Supplement). 554–554. 3 indexed citations

Rausch, Matthew, Jeremy H. Tchaicha, Thomas T. Tibbitts, et al.. (2016). Abstract B032: The PI3K-γ inhibitor, IPI-549, increases antitumor immunity by targeting tumor-associated myeloid cells and remodeling the immune-suppressive tumor microenvironment. Cancer Immunology Research. 4(11_Supplement). B032–B032. 3 indexed citations

White, Kerry, L. Kerrie, Jennifer Proctor, et al.. (2016). Abstract 376: Combination of duvelisib with either ibrutinib or dexamethasone prevents mTOR-dependent feedback in aggressive B-cell lymphoma cell lines. Cancer Research. 76(14_Supplement). 376–376. 5 indexed citations

Kerrie, L., Kerry White, Jennifer Proctor, et al.. (2015). High throughput in vitro combination sensitivity screen in hematologic malignancies with the phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib.. Journal of Clinical Oncology. 33(15_suppl). 8559–8559. 9 indexed citations

Douglas, Mark, Alice R. Lim, James R. Porter, et al.. (2009). The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activityin vivo. Molecular Cancer Therapeutics. 8(12). 3369–3378. 14 indexed citations

Mitsiades, Constantine, Nicholas Mitsiades, Joseph Negri, et al.. (2004). IPI-504: A Novel hsp90 Inhibitor with In Vitro and In Vivo Anti-Tumor Activity.. Blood. 104(11). 2403–2403. 6 indexed citations

Emerich, Dwaine F., Pamela Snodgrass, Reginald L. Dean, et al.. (2001). Bradykinin Modulation of Tumor Vasculature: I. Activation of B2 Receptors Increases Delivery of Chemotherapeutic Agents into Solid Peripheral Tumors, Enhancing Their Efficacy. Journal of Pharmacology and Experimental Therapeutics. 296(2). 623–631. 28 indexed citations

Emerich, Dwaine F., Reginald L. Dean, Pamela Snodgrass, et al.. (2001). Bradykinin Modulation of Tumor Vasculature: II. Activation of Nitric Oxide and Phospholipase A2/Prostaglandin Signaling Pathways Synergistically Modifies Vascular Physiology and Morphology to Enhance Delivery of Chemotherapeutic Agents to Tumors. Journal of Pharmacology and Experimental Therapeutics. 296(2). 632–641. 35 indexed citations

10.

Emerich, Dwaine F., Reginald L. Dean, Joanne Marsh, et al.. (2000). Intravenous Cereport (RMP-7) Enhances Delivery of Hydrophilic Chemotherapeutics and Increases Survival in Rats with Metastatic Tumors in the Brain. Pharmaceutical Research. 17(10). 1212–1219. 36 indexed citations

11.

Emerich, Dwaine F., Pamela Snodgrass, Reginald L. Dean, et al.. (1999). Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters. British Journal of Cancer. 80(7). 964–970. 48 indexed citations

12.

Emerich, Dwaine F., Pamela Snodgrass, Melissa Pink, Floyd E. Bloom, & Raymond T. Bartus. (1998). Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport™ (RMP-7). Brain Research. 801(1-2). 259–266. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact